Female sexual response: The role of drugs in the management of sexual dysfunction

Obstetrics and Gynecology

Volumn 98, Issue 2, 2001, Pages 350-353

  Basson, Rosemary ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANDROGEN; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL;

BLOOD FLOW; DYSPAREUNIA; EMOTIONALITY; FEMALE GENITAL SYSTEM; FEMALE SEXUAL DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; INTIMACY; LIBIDO; MOTIVATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SEXUAL AROUSAL; SEXUAL BEHAVIOR; STIMULUS RESPONSE;

EID: 0034890355     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(01)01452-1     Document Type: Article

References (12)

1. Sexual dysfunction in the United States: Prevalence and predictors
2. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy
3. Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury
4. Female sexual response revisited
5. Determinants of subjective experience of sexual arousal in women: Feedback from genital arousal and erotic stimulus content
6. Sexual desire and the brain
7. Women's sexuality: Behaviors, responses and individual differences
8. Intrapsychic and individual aspects of sexual desire
9. Steroid hormones, menopause, sexuality and well-being of women
10. Redefining female sexual response
11. Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications